A patient with hepatic encephalopathy and suspected spontaneous bacterial peritonitis is being managed in the ICU. Despite intensive treatment, his condition remains critical. Which nursing intervention should be prioritized to address the most life-threatening complication?

C) Increase monitoring of neurological status for signs of cerebral edema.

A) Administer intravenous albumin to improve renal perfusion.

B) Intensify lactulose administration to lower serum ammonia levels.

C) Increase monitoring of neurological status for signs of cerebral edema.

D) Initiate high-flow oxygen therapy to improve oxygen saturation.

A patient with a history of liver cirrhosis presents with altered mental status, ascites, and elevated serum ammonia levels. Despite the administration of lactulose, there is no significant improvement in his neurological function. What is the most appropriate next step in managing this patient's hepatic encephalopathy?

A) Increase the dose of lactulose

A patient with worsening ascites, suspected portal vein thrombosis, and progressive renal failure is being evaluated for potential hepatorenal syndrome type 1. Which of the following interventions should be prioritized to stabilize the patient's condition while minimizing further renal damage?

B) Initiate vasopressor therapy to maintain mean arterial pressure above 65 mmHg.

A) Aggressively increase IV fluid administration to improve renal perfusion.

B) Initiate vasopressor therapy to maintain mean arterial pressure above 65 mmHg.

C) Administer diuretics to reduce ascites and improve respiratory status.

D) Start continuous renal replacement therapy (CRRT) immediately to address metabolic acidosis.

A patient with advanced liver disease and acute kidney injury presents with worsening ascites, reduced portal vein flow, and hypotension despite aggressive fluid resuscitation. The clinical team suspects hepatorenal syndrome type 1 and severe metabolic acidosis. Which of the following nursing interventions is the most appropriate to prioritize for stabilizing the patient's condition?

B) Initiate a continuous infusion of norepinephrine to increase systemic vascular resistance and blood pressure.

A) Administer intravenous albumin to improve intravascular volume and support renal perfusion.

B) Initiate a continuous infusion of norepinephrine to increase systemic vascular resistance and blood pressure.

C) Prepare the patient for immediate paracentesis to reduce intra-abdominal pressure and improve respiratory function.

D) Start continuous renal replacement therapy (CRRT) to manage renal failure and correct metabolic acidosis.

A patient in the ICU is experiencing persistent hypotension despite norepinephrine administration, worsening metabolic acidosis, and signs of respiratory compromise. Which of the following interventions should the nurse prioritize to stabilize the patient's condition?

D) Prepare for intubation and mechanical ventilation to manage respiratory failure.

A) Increase the dose of norepinephrine to further support blood pressure.

B) Initiate continuous renal replacement therapy (CRRT) to address metabolic acidosis.

C) Administer albumin infusions to enhance circulatory volume and address hepatorenal syndrome.

D) Prepare for intubation and mechanical ventilation to manage respiratory failure.

A patient in the ICU is receiving norepinephrine for hypotension, yet their systolic blood pressure remains low. They exhibit increased respiratory distress, metabolic acidosis, and altered mental status. Which intervention should the nurse prioritize to address the patient's critical condition and prevent further deterioration?

C) Start mechanical ventilation to improve oxygenation and support respiratory function.

A) Increase the norepinephrine infusion rate to stabilize blood pressure.

B) Initiate continuous renal replacement therapy (CRRT) to manage metabolic acidosis and renal failure.

C) Start mechanical ventilation to improve oxygenation and support respiratory function.

D) Administer albumin infusions to enhance circulatory volume and improve perfusion.

A patient in the ICU is receiving continuous renal replacement therapy (CRRT) and has been initiated on mechanical ventilation due to worsening respiratory status. Recent lab results show a significant rise in liver enzymes and bilirubin levels, indicating possible acute hepatic insult. Given the patient's current condition, which nursing intervention is the highest priority to prevent further deterioration?

C) Adjust ventilator settings to improve ventilation and reduce pCO2 levels.

A) Increase the frequency of neurological assessments to monitor for worsening hepatic encephalopathy.

B) Titrate norepinephrine infusion to maintain systolic blood pressure above 100 mmHg.

C) Adjust ventilator settings to improve ventilation and reduce pCO2 levels.

D) Initiate enteral nutrition to support liver function and overall recovery.

A patient with acute-on-chronic liver failure and ongoing renal replacement therapy is experiencing hemodynamic instability and has been intubated for respiratory failure. Despite these interventions, the patient's liver function tests indicate a dramatic deterioration. As a nurse part of the critical care team, which intervention should be prioritized to address the patient's current state?

C) Consult the transplant team for urgent evaluation for liver transplantation.

A) Increase the dose of norepinephrine to stabilize blood pressure.

B) Initiate continuous renal replacement therapy at a higher dose to manage metabolic acidosis.

C) Consult the transplant team for urgent evaluation for liver transplantation.

D) Adjust ventilator settings to decrease pCO2 and improve respiratory status.

A patient with severe hepatic encephalopathy, coagulopathy, and signs of renal deterioration is being evaluated for a liver transplant. The nursing team must prioritize interventions that address the patient's complex condition. Which nursing intervention is most critical at this time?

B) Initiating vasopressor therapy to improve renal perfusion and support blood pressure.

A) Administering fresh frozen plasma to correct the coagulopathy and decrease the risk of bleeding.

B) Initiating vasopressor therapy to improve renal perfusion and support blood pressure.

C) Implementing strict fluid restriction to manage potential fluid overload and support renal function.

D) Preparing the patient for an emergent liver transplant evaluation to expedite potential transplantation.

A 56-year-old patient with severe hepatic encephalopathy and coagulopathy is also showing signs of renal deterioration, suspected hepatorenal syndrome, and is on CRRT. The patient has a GCS score of 6 and an INR of 3.5, along with a platelet count of 45,000/mm^3. Which of the following nursing actions is the highest priority in managing this complex clinical situation?

C) Adjust CRRT settings to optimize renal perfusion and manage fluid overload.

A) Administer fresh frozen plasma and platelets to correct the coagulopathy.

B) Prepare the patient for an immediate liver biopsy to evaluate the need for transplantation.

C) Adjust CRRT settings to optimize renal perfusion and manage fluid overload.

D) Initiate continuous EEG monitoring to assess for changes in neurological status.

hepatic encephalopathy - Nursing Case Study

Pathophysiology

• Primary mechanism: Ammonia accumulation due to impaired hepatic detoxification; the liver's inability to convert ammonia into urea leads to elevated systemic ammonia levels, crossing the blood-brain barrier and causing neurotoxicity.

• Secondary mechanism: Altered neurotransmission from increased ammonia and other neurotoxic substances disrupts neuronal function, contributing to cognitive and motor dysfunction.

• Key complication: Cerebral edema resulting from astrocyte swelling in response to ammonia-induced osmotic changes, potentially leading to increased intracranial pressure and severe neurological deterioration.

Patient Profile

Demographics:

57-year-old male, retired chemical engineer

History:

• Key past medical history: Cirrhosis secondary to chronic Hepatitis C, Type 2 Diabetes Mellitus, Hypertension, Chronic Kidney Disease Stage 3

• Current medications: Lactulose, Rifaximin, Metformin, Lisinopril, Furosemide, Spironolactone

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Altered mental status

• Key symptoms: Confusion, lethargy, asterixis, jaundice, abdominal distension, peripheral edema

• Vital signs: Blood pressure 92/58 mmHg, heart rate 118 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

As the clinical team begins the initial assessment of the patient, several critical findings emerge, highlighting the complexity of his condition. The patient's Glasgow Coma Scale score has decreased to 10, indicating a significant decline in neurological function. Physical examination reveals pronounced asterixis, further evidencing the severity of hepatic encephalopathy. Abdominal examination shows marked distension with shifting dullness, suggesting significant ascites, while the examination of the lower extremities reveals 3+ pitting edema. Auscultation of the lungs reveals bilateral crackles, raising concerns for potential pulmonary complications such as pleural effusions or pulmonary edema, which could be exacerbating his hypoxemia.

Laboratory results provide further insight into the patient's deteriorating condition. Serum ammonia levels are critically elevated at 145 µmol/L (normal: 11-32 µmol/L), correlating with his altered mental status. Liver function tests show a worsening picture with elevated bilirubin at 5.5 mg/dL and increased AST and ALT levels, indicating hepatic decompensation. Additionally, his renal function has deteriorated with a creatinine level of 2.3 mg/dL, suggesting a progression towards renal failure, possibly due to hepatorenal syndrome. Arterial blood gas analysis reveals a pH of 7.32, pCO2 of 35 mmHg, and HCO3 of 18 mEq/L, indicating a metabolic acidosis possibly worsened by lactic acidosis secondary to sepsis, given his fever and leukocytosis.

In response to these findings, the clinical team initiates several interventions aimed at stabilizing the patient. High-flow oxygen therapy is started to improve oxygen saturation, and intravenous albumin is administered to address the hypoalbuminemia and potentially improve renal perfusion. Lactulose administration is intensified to reduce ammonia levels, and broad-spectrum antibiotics are initiated due to the suspicion of spontaneous bacterial peritonitis or another infectious source contributing to the fever and leukocytosis. The team closely monitors the patient's neurological status and intracranial pressure, prepared to escalate care to advanced interventions if cerebral edema worsens. Despite these efforts, the patient's condition remains precarious, setting the stage for potential new complications and necessitating continuous reassessment and adjustment of the clinical management plan.

Section 2

As the clinical team continues to manage the patient, a new set of diagnostic results reveals significant changes, further complicating the clinical picture. A repeat abdominal ultrasound shows an increase in ascitic fluid volume, raising concerns for worsening portal hypertension. Additionally, a Doppler ultrasound of the hepatic vasculature identifies reduced flow in the portal vein, suggesting possible thrombosis, which could be contributing to the patient’s deteriorating hepatic function and exacerbating ascites.

The patient's laboratory results indicate an alarming rise in serum creatinine to 3.1 mg/dL, confirming the progression towards acute kidney injury. This is compounded by a drop in blood pressure to 85/50 mmHg, despite aggressive fluid resuscitation, indicating a probable transition to hepatorenal syndrome type 1. The clinical team is faced with the challenge of managing this delicate balance between addressing intravascular volume status and avoiding fluid overload, given the patient's existing pulmonary complications.

In response to these developments, the clinical team considers more advanced interventions, including the initiation of vasopressors to maintain adequate renal perfusion and the potential need for continuous renal replacement therapy (CRRT) to manage the escalating renal failure. The decision-making process is further complicated by the patient's persistent metabolic acidosis, with repeat arterial blood gas showing a pH of 7.28, highlighting the need for ongoing assessment of possible sepsis or other underlying metabolic derangements. The team must integrate these findings into a cohesive management plan, requiring advanced clinical reasoning and prioritization of interventions to stabilize the patient while preparing for further potential complications.

Section 3

As the clinical team implements advanced interventions, the patient's condition continues to evolve, revealing new complexities. Despite the initiation of vasopressors, specifically norepinephrine, to counteract hypotension and support renal perfusion, the patient's systolic blood pressure remains tenuous, fluctuating between 85 and 95 mmHg. The team notes a marginal improvement in renal output with urine output increasing to 15 mL/hour, yet it remains critically low. Concurrently, the patient's respiratory status becomes increasingly compromised, as evidenced by an increase in respiratory rate to 32 breaths per minute and declining oxygen saturation levels, now at 88% on a non-rebreather mask. These findings suggest a deterioration in pulmonary function, possibly related to fluid overload from aggressive resuscitation efforts, or pulmonary infection.

Further complicating the clinical picture, a repeat arterial blood gas shows worsening metabolic acidosis with a pH dropping to 7.25, HCO3- of 16 mEq/L, and a base excess of -8. The lactate level is elevated at 4.5 mmol/L, raising suspicion for lactic acidosis secondary to poor tissue perfusion and potential sepsis. Blood cultures are obtained, and broad-spectrum antibiotics are initiated preemptively. Despite these efforts, the patient exhibits signs of altered mental status, with increased confusion and disorientation, indicative of worsening hepatic encephalopathy and possible progression to grade III.

In light of these developments, the clinical team faces the pressing need to reassess the management plan. The decision to initiate continuous renal replacement therapy (CRRT) is now imperative to address the escalating renal failure and ongoing metabolic acidosis. Furthermore, the team contemplates the use of albumin infusions in conjunction with vasopressors to enhance circulatory function and mitigate hepatorenal syndrome. The patient's deteriorating respiratory status prompts consideration of mechanical ventilation support to ensure adequate oxygenation and carbon dioxide clearance, recognizing the delicate balance required to avoid exacerbating the patient's hemodynamic instability. The team must navigate these interventions judiciously, while remaining vigilant for further complications that may arise.

Section 4

Following the initiation of continuous renal replacement therapy (CRRT), the clinical team closely monitors the patient's response, keenly aware of the potential for further hemodynamic instability. Within the first few hours, there is a subtle improvement in metabolic parameters: the pH begins to correct, rising to 7.30, and the bicarbonate level shows a slight increase to 18 mEq/L. Despite these encouraging signs, the patient's hemodynamics remain precarious, with systolic blood pressure oscillating between 80 and 90 mmHg, even with ongoing norepinephrine support. The decision is made to cautiously initiate low-dose dobutamine to augment cardiac output and improve organ perfusion.

During this period, the patient's respiratory status demands urgent attention. The increasing work of breathing and persistent hypoxemia necessitate the initiation of mechanical ventilation. The team performs a rapid sequence intubation, and the patient is placed on a volume-controlled ventilation mode with settings tailored to optimize oxygenation while minimizing the risk of further hemodynamic compromise. Post-intubation, arterial blood gases reveal a partial improvement in oxygenation, with the PaO2 rising to 65 mmHg and oxygen saturation increasing to 92%. However, the underlying ventilatory failure persists, as indicated by a pCO2 of 55 mmHg, necessitating careful titration of ventilator settings.

As the patient settles into mechanical ventilation, the team reviews the latest laboratory results, which reveal an alarming development: the liver function tests show a dramatic deterioration. The AST and ALT levels have spiked to over 2000 IU/L, and the bilirubin level has surged to 8.5 mg/dL. These findings, combined with the ongoing hepatic encephalopathy, suggest an acute hepatic insult, possibly an ischemic hepatitis or worsening acute-on-chronic liver failure. The team must now consider the potential need for advanced liver support therapies or even evaluation for liver transplantation, all while managing the delicate interplay of systemic complications. This critical juncture underscores the complexity of the case, requiring astute clinical reasoning and strategic decision-making to navigate the patient's intricate and evolving condition.

Section 5

The patient's condition continues to evolve, and within the next several hours, a new set of complications emerges that further complicates the clinical picture. Despite the gradual stabilization of metabolic parameters, the patient's neurological status deteriorates. The nursing team notices a marked decrease in responsiveness, with the patient now exhibiting a Glasgow Coma Scale (GCS) score of 6. This change prompts an urgent neurological assessment, including an electroencephalogram (EEG), which reveals generalized slowing consistent with severe hepatic encephalopathy. The team must now balance the need for aggressive management of encephalopathy with the patient's hemodynamic instability and respiratory failure.

Meanwhile, the latest laboratory results add another layer of complexity. Coagulation studies show a significant coagulopathy with an international normalized ratio (INR) of 3.5 and a platelet count that has dropped to 45,000/mm^3. This raises concerns about the risk of bleeding complications, particularly given the potential need for invasive interventions such as liver biopsy or insertion of additional central lines. The team discusses the judicious use of blood products, including fresh frozen plasma and platelets, to address the coagulopathy while carefully monitoring for transfusion-associated circulatory overload.

As the team navigates these challenges, they must also contend with a new development: signs of renal deterioration, despite CRRT. The patient's urine output diminishes significantly, and creatinine levels rise to 3.2 mg/dL. This renal setback raises the possibility of hepatorenal syndrome, a grave complication that could further compromise the patient's chances of recovery without liver transplantation. The clinical team must now consider the delicate balance of fluid management, the potential need for vasopressor adjustments, and the implications for the patient's eligibility for liver transplant evaluation. This multifaceted situation demands high-level critical thinking, as every decision could have significant repercussions for the patient's overall trajectory.